Work

The Role of 18f-FDG-PET/CT in Characterizing Depth of Response in High Risk Smoldering Multiple Myeloma Patients Treated with Carfilzomib, Lenalidomide, and Dexamethasone (KRd)

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-136182

Authors: Elizabeth Hill, Neha Korde, Candis Morrison, Alexander Dew, Ashley Carpenter, Monica Epstein, Crystal Lu, Peter Choyke, Esther Mena, Liza Lindenberg, Ola Landgren, Dickran Kazandjian

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Memorial Sloan Kettering Cancer Center, Walter Reed National Military Medical Center, National Institutes of Health Clinical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097842643

FWCI:

Cites:

Cited by:

Related to: 10